Ohio Public Employees Retirement System (OPERS)’s C4 Therapeutics CCCC Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio CCCC Stock Details CCCC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-71,163	Closed	-$132K	–	1980
2023 Q3	$132K	Sell	71,163 -136,293	-66%	-$416K	﹤0.01%	1409
2023 Q2	$571K	Buy	207,456 +10,411	+5%	+$33.5K	﹤0.01%	1257
2023 Q1	$619K	Hold	197,045	–	–	﹤0.01%	1238
2022 Q4	$1.16M	Sell	197,045 -34,921	-15%	-$290K	0.01%	1132
2022 Q3	$2.03M	Buy	231,966 +4,241	+2%	+$44K	0.01%	1024
2022 Q2	$1.72M	Buy	227,725 +179,740	+375%	+$1.58M	0.01%	1120
2022 Q1	$1.16M	Buy	47,985 +10,863	+29%	+$264K	﹤0.01%	1213
2021 Q4	$1.2M	Hold	37,122	–	–	﹤0.01%	1223
2021 Q3	$1.66M	Hold	37,122	–	–	0.01%	1165
2021 Q2	$1.41M	Hold	37,122	–	–	0.01%	1209
2021 Q1	$1.37M	Buy	+37,122	New	+$1.48M	0.01%	1161

Other funds holding CCCC

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS)'s CCCC Position: Q4 2023 in Review

Ohio Public Employees Retirement System (OPERS) sold out of C4 Therapeutics (CCCC) in Q4 2023, closing a stake of 71,163 shares — an estimated $132K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in CCCC in Q1 2021 and held it in 11 quarters. The position peaked at $2.03M in Q3 2022. 92 funds tracked by Wall St. Rank hold CCCC as of Q4 2023.

Ohio Public Employees Retirement System (OPERS) reported no remaining C4 Therapeutics position as of Q4 2023 after selling out during the quarter.
Ohio Public Employees Retirement System (OPERS) sold 71,163 C4 Therapeutics shares in Q4 2023, an estimated $132K.
Ohio Public Employees Retirement System (OPERS) first reported a position in C4 Therapeutics in Q1 2021 and held it in 11 quarters.
Ohio Public Employees Retirement System (OPERS)'s C4 Therapeutics position peaked at $2.03M in Q3 2022.
92 funds tracked by Wall St. Rank held C4 Therapeutics as of Q4 2023.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q4 2023, filed 16 Feb 2024.